Efficacy of a standardized extract of Matricariae chamomilla L., Melissa officinalis L. and tyndallized Lactobacillus acidophilus (HA122) in infantile colic: An open randomized controlled trial

Neurogastroenterology and Motility

Volumn 29, Issue 12, 2017, Pages

  Martinelli, M ^a   Ummarino, D ^a   Giugliano, F P ^a   Sciorio, E ^a   Tortora, C ^a   Bruzzese, D ^a   De Giovanni, D ^b   Rutigliano, I ^b   Valenti, S ^c   Romano, C ^c   Campanozzi, A ^b   Miele, E ^a   Staiano, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

complementary and alternative medicine; herbal supplement; infantile colic; probiotics

Indexed keywords

COLIMIL; DIGESTIVE TRACT AGENT; DSM 17938; LACTOBACILLUS ACIDOPHILUS EXTRACT; MATRICARIA CHAMOMILLA EXTRACT; MELISSA OFFICINALIS EXTRACT; PLANT EXTRACT; PLUS; SIMETHICONE; UNCLASSIFIED DRUG; PROBIOTIC AGENT;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYING; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFANTILE COLIC; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MALE; MATRICARIA CHAMOMILLA; MELISSA OFFICINALIS; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ALTERNATIVE MEDICINE; CLINICAL TRIAL; COLIC; MATRICARIA; NEWBORN; PROCEDURES;

COLIC; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS ACIDOPHILUS; MALE; MATRICARIA; MELISSA; PLANT EXTRACTS; PROBIOTICS;

EID: 85021710914     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.13145     Document Type: Article

References (40)

1. Wake M, Morton-Allen E, Poulakis Z, Hiscock H, Gallagher S, Oberklaid F. Prevalence, stability, and outcomes of cry-fuss and sleep problems in the first 2 years of life: prospective community-based study. Pediatrics. 2006;117:836-842.
2. Lucassen PL, Assendelft WJ, van Eijk JT, Gubbels JW, Douwes AC, van Geldrop WJ. Systematic review of the occurrence of infantile colic in the community. Arch Dis Child. 2001;84:398-403.
3. Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006;130:1519-1526.
4. Camilleri M, Park SY, Scarpato E, Staiano A. Exploring hypotheses and rationale for causes of infantile colic. Neurogastroenterol Motil. 2017;29. https://doi.org/10.1111/nmo.12943.
5. Petzoldt J, Wittchen HU, Wittich J, Einsle F, Höfler M, Martini J. Maternal anxiety disorders predict excessive infant crying: a prospective longitudinal study. Arch Dis Child. 2014;99:800-806.
6. Lee C, Barr RG, Catherine N, Wicks A. Age-related incidence of publicly reported shaken baby syndrome cases: is crying a trigger for shaking? J Dev Behav Pediatr. 2007;28:288-293.
7. Howard CR, Lanphear N, Lanphear BP, Eberly S, Lawrence RA. Parental responses to infant crying and colic: the effect on breastfeeding duration. Breastfeed Med. 2006;1:146-155.
8. Morris S, James-Roberts IS, Sleep J, Gillham P. Economic evaluation of strategies for managing crying and sleeping problems. Arch Dis Child. 2001;84:15-19.
9. Cohen-Silver J, Ratnapalan S. Management of infantile colic: a review. Clin Pediatr. 2009;48:14-17.
10. Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (America Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007;119:e124-e130.
11. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17 938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126:e256-33.
12. Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013;162:257-262.
13. Sung V, Hiscock H, Tang ML, et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ. 2014;348:2107.
14. Harb T, Matsuyama M, David M, Hill RJ. Infant colic-what works: a systematic review of interventions for breast-fed infants. J Pediatr Gastroenterol Nutr. 2016;62:668-686.
15. Perry R, Hunt K, Ernst E. Nutritional supplements and other complementary medicines for infantile colic: a systematic review. Pediatrics. 2011;127:720-733.
16. Savino F, Cresi F, Castagno E, Silvestro L, Oggero R. A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytother Res. 2005;19:335-340.
17. Tsilingiri K, Barbosa T, Penna G, et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut. 2012;61:1007-1015.
18. Cicenia A, Scirocco A, Carabotti M, Pallotta L, Marignani M, Severi C. Postbiotic activities of lactobacilli-derived factors. J Clin Gastroenterol. 2014;48(Suppl 1):S18-S22.
19. Alves JG, de Brito Rde C, Cavalcanti TS. Effectiveness of Mentha piperita in the treatment of infantile colic: a crossover study. Evid Based Complement Alternat Med. 2012;2012:981352.
20. Barr RG, Kramer MS, Leduc DG, McVey-White L, Pless IB. Parental diary of infant cry and fuss behavior. Arch Dis Child. 1988;63:380-387.
21. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
22. Vandenplas Y, Abkari A, Bellaiche M, et al. Prevalence and health outcomes of functional gastrointestinal symptoms in infants from birth to 12 months of age. J Pediatr Gastroenterol Nutr. 2015;61:531-537.
23. van Tilburg MA, Hyman PE, Walker L, et al. Prevalence of functional gastrointestinal disorders in infants and toddlers. J Pediatr. 2015;166:684-689.
24. Capasso R, Savino F, Capasso F. Effects of the herbal formulation ColiMil on upper gastrointestinal transit in mice in vivo. Phytother Res. 2007;21:999-1101.
25. Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): an overview. Pharmacogn Rev. 2011;5:82-95.
26. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29:378-382.
27. Dell'Agli M, Di Lorenzo C, Badea M, et al. Plant food supplements with anti-inflammatory properties: a systematic review. Crit Rev Food Sci Nutr. 2013;53:403-413.
28. Maschi O, Cero ED, Galli GV, Caruso D, Bosisio E, Dell'Agli M. Inhibition of human cAMP-phosphodiesterase as a mechanism of the spasmolytic effect of Matricaria recutita L. J Agric Food Chem. 2008;56:5015-5020.
29. Mehmood MH, Munir S, Khalid UA, Asrar M, Gilani AH. Antidiarrhoeal, antisecretory and antispasmodic activities of Matricaria chamomilla are mediated predominantly through K(+)-channels activation. BMC Complement Altern Med. 2015;15:75.
30. Soulimani R, Younas C, Fleurentin J, Mortier F, Misslin R, Derrieux G. Biological activity study of Melissa officinalis on central nervous system by in vivo mouse and duodenum of in vitro rat. Plant Med Phytother. 1993;26:77-85.
31. Feliú-Hemmelmann K, Monsalve F, Rivera C. Melissa officinalis and Passiflora caerulea infusion as physiological stress decreaser. Int J Clin Exp Med. 2013;6:444-451.
32. Hajhashemi V, Safaei A. Hypnotic effect of Coriandrum sativum, Ziziphus jujuba, Lavandula angustifolia and Melissa officinalis extracts in mice. Res Pharm Sci. 2015;10:477-484.
33. Chau K, Lau E, Greenberg S, et al. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr. 2015;166:74-78.
34. Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr. 2009;98:1582-1588.
35. de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013;131:e550-e558.
36. Kannampalli P, Pochiraju S, Chichlowski M, et al. Probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats. Neurogastroenterol Motil. 2014;26:1694-1704.
37. Wu RY, Pasyk M, Wang B, et al. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol Motil. 2013;25:e205-e214.
38. Liévin-Le Moal V. A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB. Therap Adv Gastroenterol. 2016;9:57-75.
39. Huang IF, Lin IC, Liu PF, et al. Lactobacillus acidophilus attenuates Salmonella-induced intestinal inflammation via TGF-β signaling. BMC Microbiol. 2015;15:203.
40. Patman G. Gut microbiota: Lactobacillus acidophilus opens the door to butyrate. Nat Rev Gastroenterol Hepatol. 2015;12:552.